BKBG
CYTK icon

BHF Kleinwort Benson Group’s Cytokinetics CYTK Stock Holding History

BHF Kleinwort Benson Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$36K – 543
2014
Q2 		$36K Sell
10,000
-2,000
-17% -$12.2K ﹤0.01% 489
2014
Q1 		$78K Buy
+12,000
New +$109K ﹤0.01% 470

Other funds holding CYTK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
IIM
Ironwood Investment Management Boston, Massachusetts $240M AUM 45.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BHF Kleinwort Benson Group's CYTK Position: Q3 2014 in Review

BHF Kleinwort Benson Group sold out of Cytokinetics (CYTK) in Q3 2014, closing a stake of 10,000 shares — an estimated $36K sold.

BHF Kleinwort Benson Group first reported a position in CYTK in Q1 2014 and held it in 2 quarters. The position peaked at $78K in Q1 2014. 85 funds tracked by Wall St. Rank hold CYTK as of Q3 2014.

  • BHF Kleinwort Benson Group reported no remaining Cytokinetics position as of Q3 2014 after selling out during the quarter.
  • BHF Kleinwort Benson Group sold 10,000 Cytokinetics shares in Q3 2014, an estimated $36K.
  • BHF Kleinwort Benson Group first reported a position in Cytokinetics in Q1 2014 and held it in 2 quarters.
  • BHF Kleinwort Benson Group's Cytokinetics position peaked at $78K in Q1 2014.
  • 85 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2014.

Based on BHF Kleinwort Benson Group's 13F filing for Q3 2014, filed 20 Feb 2015.